Citation: Ul. Mullins et al., MELATONIN AGONISTS INDUCE PHOSPHOINOSITIDE HYDROLYSIS IN XENOPUS-LAEVIS MELANOPHORES, Cellular signalling, 9(2), 1997, pp. 169-173
Citation: As. Eison et Ul. Mullins, REGULATION OF CENTRAL 5-HT2A RECEPTORS - A REVIEW OF IN-VIVO STUDIES, Behavioural brain research, 73(1-2), 1995, pp. 177-181
Authors:
TAYLOR DP
CARTER RB
EISON AS
MULLINS UL
SMITH HL
TORRENTE JR
WRIGHT RN
YOCCA FD
Citation: Dp. Taylor et al., PHARMACOLOGY AND NEUROCHEMISTRY OF NEFAZODONE, A NOVEL ANTIDEPRESSANTDRUG, The Journal of clinical psychiatry, 56, 1995, pp. 3-11
Authors:
EISON AS
FREEMAN RP
GUSS VB
MULLINS UL
WRIGHT RN
Citation: As. Eison et al., MELATONIN AGONISTS MODULATE 5-HT2A RECEPTOR-MEDIATED NEUROTRANSMISSION - BEHAVIORAL AND BIOCHEMICAL-STUDIES IN THE RAT, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 304-308
Citation: Ul. Mullins et As. Eison, PHARMACOLOGICAL CHARACTERIZATION OF MELATONIN-MEDIATED PHOSPHOINOSITIDE HYDROLYSIS IN PIGEON BRAIN, Journal of pineal research, 17(1), 1994, pp. 33-38
Citation: As. Eison et Ms. Eison, SEROTONERGIC MECHANISMS IN ANXIETY, Progress in neuro-psychopharmacology & biological psychiatry, 18(1), 1994, pp. 47-62
Authors:
GEISSLER MA
TORRENTE JR
EISON AS
GYLYS JA
WRIGHT RN
IBEN LG
DAVIS HH
YOCCA FD
Citation: Ma. Geissler et al., EFFECTS OF BMY-33462, A SELECTIVE AND POTENT SEROTONIN TYPE-3 RECEPTOR ANTAGONIST, ON MESOLIMBIC DOPAMINE-MEDIATED BEHAVIOR, Drug development research, 29(1), 1993, pp. 18-24
Citation: K. Bohmaker et al., COMPARATIVE EFFECTS OF CHRONIC 8-OH-DPAT, GEPIRONE AND IPSAPIRONE TREATMENT ON THE SENSITIVITY OF SOMATODENDRITIC 5-HT1A AUTORECEPTORS, Neuropharmacology, 32(6), 1993, pp. 527-534
Citation: As. Eison et Ul. Mullins, MELATONIN BINDING-SITES ARE FUNCTIONALLY COUPLED TO PHOSPHOINOSITIDE HYDROLYSIS IN SYRIAN-HAMSTER RPMI-1846 MELANOMA-CELLS, Life sciences, 53(24), 1993, pp. 393-398